Econ Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-24,367
Closed -$2.02M 107
2025
Q2
$2.02M Sell
24,367
-1,067
-4% -$85.1K 1.04% 32
2025
Q1
$2.06M Buy
25,434
+3,824
+18% +$342K 1.1% 30
2024
Q4
$1.95M Buy
+21,610
New +$2.09M 1.12% 30
2022
Q3
Sell
-8,382
Closed -$623K 110
2022
Q2
$623K Buy
8,382
+576
+7% +$43.2K 0.5% 48
2022
Q1
$702K Buy
+7,806
New +$721K 0.52% 44

Other funds holding XBI

Econ Financial Services's XBI Position: Q3 2025 in Review

Econ Financial Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 24,367 shares — an estimated $2.02M sold.

Econ Financial Services first reported a position in XBI in Q1 2022 and held it in 5 quarters. The position peaked at $2.06M in Q1 2025. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • Econ Financial Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
  • Econ Financial Services sold 24,367 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $2.02M.
  • Econ Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and held it in 5 quarters.
  • Econ Financial Services's State Street SPDR S&P Biotech ETF position peaked at $2.06M in Q1 2025.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Econ Financial Services's 13F filing for Q3 2025, filed 21 Oct 2025.